Johnson & Johnson has paused its clinical trials for a Covid-19 vaccine candidate after a participant fell ill, just weeks after it announced that trials were in their final stage.
The trial was paused in compliance with regulatory standards after an "unexplained" illness in one of its participants, the company said.Mark Kauzlarich / Bloomberg via Getty Images fileJohnson & Johnson has paused its clinical trials for a Covid-19 vaccine candidate after a participant fell ill, justA pause is not entirely unexpected in vaccine trials.
The Johnson & Johnson trial was paused in compliance with regulatory standards after one of its participants developed an"unexplained" illness,. It said the participant's condition was being reviewed and evaluated by the ENSEMBLE independent Data Safety Monitoring Board. "We must respect this participant's privacy," the company's statement said."We're also learning more about this participant's illness, and it's important to have all the facts before we share additional information."
It is unclear whether the participant received the experimental vaccine or was in the placebo control group.AstraZeneca also started its phase 3 trial of a vaccine candidate last month, but it was placed on pause in the U.S. after a participant in the United Kingdom
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Johnson & Johnson Pauses Covid-19 Vaccine Trials Due to Sick SubjectThe company says an independent committee is reviewing the subject’s illness, and it will review the medical information before deciding whether to restart the studies
Read more »
Johnson & Johnson pauses Covid-19 vaccine trial after 'unexplained illness'Johnson&Johnson said its Janssen arm had paused its coronavirus vaccine trial after an 'unexplained illness' in one of the volunteers testing its experimental Covid-19 shot.
Read more »
Johnson & Johnson pauses clinical trials for a Covid vaccine over patient illnessThe trial was paused after an “unexplained” illness in one of its participants and in compliance with regulatory standards, the company said.
Read more »
2nd COVID-19 vaccine trial paused over unexplained illnessBREAKING: Johnson & Johnson pauses its COVID-19 vaccine trial while the company investigates a participant’s “unexplained illness.” The company said such illnesses, accidents and similar adverse events are an expected part of large clinical studies.
Read more »
8 Reasons Covid-19 Coronavirus Could Get Worse With Fall ‘Second Wave’How changes in humidity, temperature, and other things may increase the transmission of the virus and cause a surge in cases and deaths.
Read more »